Ericsson Plans SEK 25 Billion Shareholder Returns as Margins Improve Despite Flat Network Market 
Lynas Rare Earths Shares Surge as Quarterly Revenue Jumps on Strong Prices 
Microsoft Restores Microsoft 365 Services After Widespread Outage 
Global DRAM Chip Shortage Puts Automakers Under New Cost and Supply Pressure 
Walmart to Cut PhonePe Stake in IPO as Tiger Global and Microsoft Exit 
JPMorgan and Allen & Company Emerge as Big Winners in Warner Bros Discovery Bidding War 
United Airlines Posts Record Q4 Revenue as Premium Demand Lifts Earnings 
Court Allows Expert Testimony Linking Johnson & Johnson Talc Products to Ovarian Cancer 
Sanofi Reports Positive Late-Stage Results for Amlitelimab in Eczema Treatment 
Intel Stock Slides Despite Earnings Beat as Weak Q1 Outlook Raises Concerns 
Valero Makes First Venezuelan Crude Purchase Under New U.S.-Caracas Deal 
Baidu Shares Surge After Official Launch of Advanced Ernie 5.0 AI Model 
SoftBank Shares Surge as AI Optimism Lifts Asian Tech Stocks 
Elon Musk Shares Bold Vision for AI, Robots, and Space at Davos 
Morgan Stanley Flags High Volatility Ahead for Tesla Stock on Robotaxi and AI Updates 
Tesla Plans FSD Subscription Price Hikes as Autonomous Capabilities Advance 
Apple Stock Jumps as Company Prepares Major Siri AI Chatbot Upgrade 
TEANECK, N.J., May 04, 2017 -- Phibro Animal Health Corporation (NASDAQ:PAHC) Chairman, President and Chief Executive Officer Jack Bendheim and Chief Financial Officer Richard Johnson will address financial analysts and investors at the Bank of America Merrill Lynch 2017 Health Care Conference.
| When: | Thursday, May 18, 2017 | |
| Time: | 10:00 AM PDT | |
| Location: | Encore at the Wynn | |
| Las Vegas, Nevada | ||
| Presentation: | Visit http://investors.pahc.com |
The presentation will be available concurrent with the live presentation.
About Phibro Animal Health Corporation
Phibro Animal Health Corporation is a diversified global developer, manufacturer and marketer of a broad range of animal health and mineral nutrition products for use in the production of poultry, swine, cattle, dairy and aquaculture. The company reported net sales of $752 million for the fiscal year ended June 30, 2016. For further information, please visit www.pahc.com.
Our filings with the Securities and Exchange Commission are available online at www.sec.gov, www.pahc.com or on request from the company.
Contact: Richard Johnson Phibro Animal Health Corporation Chief Financial Officer +1-201-329-7300 [email protected]
